Morgan Stanley’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $380 | Hold |
|
|||||
|
2023
Q2 | $307 | Hold |
|
|||||
|
2023
Q1 | $198 | Sell |
|
|||||
|
2022
Q4 | $146 | Buy |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $3K | Buy |
|
|||||
|
2021
Q4 | $2K | Buy |
|
|||||
|
2021
Q3 | $1K | Sell |
|
|||||
|
2021
Q2 | $39K | Buy |
|
|||||
|
2021
Q1 | $5K | Sell |
|
|||||
|
2020
Q4 | $129K | Buy |
|
|||||
|
2020
Q3 | $8K | Sell |
|
|||||
|
2020
Q2 | $227K | Buy |
|
|||||
|
2020
Q1 | $147K | Sell |
|
|||||
|
2019
Q4 | $1.23M | Buy |
|
|||||
|
2019
Q3 | $334K | Buy |
|
|||||
|
2019
Q2 | $649K | Buy |
|
|||||
|
2019
Q1 | $40K | Sell |
|
|||||
|
2018
Q4 | $413K | Sell |
|
|||||
|
2018
Q3 | $617K | Sell |
|
|||||
|
2018
Q2 | $785K | Buy |
|